title: [The adherence in the treatment of chronic hepatitis C].
abstract: The most effective therapy for patients with chronic hepatitis C is combined therapy with pegylated interferon plus ribavirin. Adherence has been shown to enhance the sustained viral response (SVR) in patients receiving standard or pegylated interferon plus ribavirin. Treatment - related side effects affects on treatment quality of life and impact upon the ability of a patient to adhere to treatment. It is essential that they are managed quickly and effectively. In the work authors presented side effect of the therapy of chronic hepatitis C and management of this side effects providing to reduction them.
authors.affiliation: Katedra i Klinika Chorób Zakaźnych i Hepatologii Cellegium Medicum UMK, Bydgoszcz. kikchzak@amb.bydgoszcz.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Pawłowska
authors.forename: Waldemar
authors.initials: W
authors.lastname: Halota
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects*; D011788:Quality of Life; D012254:Ribavirin / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons